e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Latest news on miRNAs in pulmonary research
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
MiR-320d: A novel anti-inflammatory miRNA up regulated by corticosteroids
Alen Faiz (Groningen, Netherlands), Alen Faiz, Malte Borggrewe, Dirkje Postma, Katrina Steiling, Avrum Spira, Marc Lenburg, Marnix Jonker, Gerard Koppelman, Pieter Hiemstra, Peter Sterk, Wim Timens, Corry-Anke Brandsma, Maarten Van den Berge, Irene Heijink
Source:
International Congress 2015 – Latest news on miRNAs in pulmonary research
Session:
Latest news on miRNAs in pulmonary research
Session type:
Oral Presentation
Number:
2927
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Alen Faiz (Groningen, Netherlands), Alen Faiz, Malte Borggrewe, Dirkje Postma, Katrina Steiling, Avrum Spira, Marc Lenburg, Marnix Jonker, Gerard Koppelman, Pieter Hiemstra, Peter Sterk, Wim Timens, Corry-Anke Brandsma, Maarten Van den Berge, Irene Heijink. MiR-320d: A novel anti-inflammatory miRNA up regulated by corticosteroids. Eur Respir J 2015; 46: Suppl. 59, 2927
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Enhanced anti-inflammatory gene expression in humans following inhaled budesonide
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Cytokine-induced glucocorticoid resistance: Effect on GILZ expression and reversal by formoterol
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Proteome profiling reveals candidate mediators of TGF-β-induced glucocorticoid resistance
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Validating SIK as a novel COPD target using four different human systems
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
The expression of the negative regulator of gene transcription SOCS3 as the crucial marker in the asthma pathogenesis
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
Transcriptional analysis of the human BPIFA1/SPLUNC1 gene
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
The role of WNT5a in Th17 asthma
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
MicroRNA-146a and microRNA-155 expression in induced sputum of allergic asthmatics
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
The effects of INTS12 knockdown on processing of snRNAs
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
Steroid resistance in COPD is associated with impaired molecular chaperone HSP90 expression by pro-inflammatory lymphocytes
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Estrogen-regulated miRNA-19b modulates the expression of secretory leukoprotease inhibitor in monocytes
Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways
Year: 2013
Effects of formoterol on the molecular mechanisms of corticosteroid resistance in models with high oxidative stress
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
Different roles for PI3Kgamma and δ in asthma
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
New outlook on the Th1/Th2-alternative signaling pathways in asthma
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Anti-inflammatory action of Gibberellin in lung epithelial cells is mediated by modification of NF-κB related kinase expression
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014
Therapeutic potential of CPL-407-105 – Novel potent JAK/STAT pathway inhibitor for the treatment of asthma
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014
Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
In vivo effects of corticosteroid plus long-acting beta2-agonist on the expression of B7-H1/PD-L1 in double-stranded RNA-induced lung inflammation
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept